$604.84
Fair Price Index
The fair price of a share represents the true value of the company's share based on its financial condition and performance. Unlike the current market price, which can fluctuate depending on the mood of the market, the fair price provides us with a better understanding of whether the share is truly advantageous.
Eli Lilly and Company (LLY) is an American pharmaceutical company with a long history and significant influence in the global pharmaceutical market. The company specializes in research, development, and manufacturing of medicinal products in various therapeutic areas, including diabetology, oncology, neurology, and others. Eli Lilly offers a wide range of pharmaceutical products and treatment approaches that help improve the health and quality of life of patients worldwide. The company invests in innovation and research to bring new drugs and treatment methods that could potentially change the way diseases are treated. Eli Lilly and Company is a respected name in the pharmaceutical industry and has a strong foundation for further growth and development. Investing in Eli Lilly and Company (LLY) shares may represent an attractive choice for investors seeking a reliable and innovative company in the healthcare sector.
Hey investors, whose results are you waiting for this week? I only have $PFE and $LLY, but I'll definitely check out Palantir, SoFi, chipmakers (AMD, Qualcomm) and PayPal.
Healthcare sector, one of the most popular sectors for investors, especially value investors. What are we going to think, health is the one thing we should protect most in our lives, and companies that are involved in this will profit from it perhaps indefinitely. Thanks to them, our society is able to live to a ripe old age. who are your favourites in this sector? For me, I... Read more
US pharmaceutical company Eli Lilly and Company reported its results today, which beat expectations and $LLY shares are up more than 15% in response. Fundamentals are quite solid and the stock is up over 40% for the year, which I like and since I see potential in healthcare and I like pharmaceutical and medical companies, I like this company even more :D. The stock may be up,... Read more
In Patria's coverage, there's one more link "Unexpectedly good quarterly numbers came together today with results from Novo Nordisk's clinical trial for rival Wegova. As Mounjaro is based on a similar principle (GLP-1/GIP analogue), its indication is expected to be extended to cardiovascular disease in the future as well."
In an intermediate clinical trial, the highest dose of Eli Lilly's experimental orforglipron $LLY pill led to a 14.7% weight loss in obese or overweight people after 36 weeks, setting a new milestone in the race to develop effective anti-obesity pills.
I think it will be appreciated by far more people than just the Americans... imagine what results you could achieve if you ate right, exercised + supported it with similar pills? What normally takes you a year you could have in a few weeks... :)
Charlie Munger and his view of healthcare in the US.
Charlie, a friend, partner of Warren, has recently been vocal about his concerns about US healthcare, literally stating that it is a system that prolongs death to make more money and comparing patients to African carcasses. 🤔
A bit off topic from the classic stocks we cover here, but if we look at the most capitalised US companies, the top ranks are also companies like $UNH$LLY$PG etc. Which according to the chart appear to be endlessly growing companies, which I admit I don't know as much about as the companies we all know like Microsoft, Apple... Do you own any of these companies that don't get... Read more
I'm a bit late in replying, but I want to look at the results of $SYK, $AAPL, $MNST and $WPC tomorrow.